The abstract is read at the publisher; the summary is JClub's.
Eight international randomized PCI trials with more than 1,000 patients each have generated substantial evidence on intracoronary imaging guidance, but results remain heterogeneous across real-world settings.
- Why it matters: Net clinical benefit has been uncertain because imaging can increase costs and procedural time, while trial populations and imaging criteria vary and randomized findings are mixed.
- What they did: The Review synthesizes study characteristics and procedural aspects from ILUMIEN IV, IVUS-ACS, IVUS-CHIP, IVUS-XPL, OCCUPI, OCTOBER, RENOVATE-COMPLEX-PCI, and ULTIMATE to assess when and how ICI guidance is appropriate.
- The result: The appraisal clarifies “why, when, how and which” for contemporary PCI decision-making, aiming to improve safety and outcomes despite protocol heterogeneity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.